On February 21, the FDA announced that the shortage of semaglutide injection products has been resolved. Semaglutide has appeared on the FDA’s Drug Shortage List since 2022 because demand for the drug exceeded the available supply. Initially developed and utilized for treatment of Type 2 diabetes, semaglutide and other
